Conclusions
The results of our study show that patients with both vitiligo and melasma achieve earlier and more extensive repigmentation on the face and limbswithNB-UVB treatment compared with patients with vitiligo alone.
It is thus recommended that patients with both vitiligo and melasma with face or limb involvement are treated with NB-UVB phototherapy. A controlled study involving psoralen plus UVA may be conducted to see if treatment of patients with truncal vitiligo, with and without melasma, is superior to NB-UVB phototherapy alone.
Acknowledgments
No sources of funding were used to conduct this study. The authors have no conflicts of interest that are directly relevant to the content of this study.
Am J Clin Dermatol. 2011;12(2):127-132. © 2011 Adis Data Information BV
Comments